- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 340 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2024
- 92 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- October 2023
- 83 Pages
Global
From €3500EUR$4,186USD£3,088GBP
The Biological Imaging Reagent market is a subset of the Medical Imaging industry. It is composed of products used to enhance the visibility of biological structures and processes in medical imaging. These reagents are used to improve the contrast of images, allowing for more accurate diagnosis and treatment. They are also used to detect and quantify biomarkers, which can be used to monitor disease progression and response to treatment. Biological Imaging Reagents are used in a variety of medical imaging modalities, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and positron emission tomography (PET).
Some companies in the Biological Imaging Reagent market include Thermo Fisher Scientific, Merck KGaA, PerkinElmer, Bio-Rad Laboratories, and Agilent Technologies. Show Less Read more